NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

Regulatory supervision and justice for small biotech companies -- don't hold your breaths for it -- SEC's exists for market stability, meaning to protect big companies, including bad players.

In the case of nwbo, Mr. Black serves as deterrent, nothing more or less; if the trial is a success, market will take care of itself at least within a period of time; unless there are substantial evidences collected and submitted to SEC or the court, there would be very difficult for due recourse.

I don't think yesterday's bizarre recurrence of wrong designation of nwbo as pink is not coincidental or accidental (I also asked for someone here to contact Innes while I myself had contacted OTC Market and the company). Be prepared for future "blackout" of even message boards, and general and specific misinformation as we approach the inflection point.

Most people may have not realized the true beauty of DCVax platform is not that we can see a successful DCVax-L trial in GBM indication, in a way of statistical significance in survival and PFS, or indisputable survival long tail over historicals and concurrent results, but that the concept or the mechanism of action of the platform can be proved.

As a result, the platform will work on other indications, and the process to get regulatory approvals for other many indications will be expedited or very short.

Has to run, GL [not intended to reply to photonic5's specific post, sorry]